The Department of Health and Human Services (HHS) recently awarded Moderna a substantial $590 million grant to accelerate the development of an mRNA vaccine against avian influenza, specifically the H5N1 strain. This significant investment underscores the growing concern surrounding the potential for a widespread bird flu outbreak.
The high mortality rate associated with H5N1, particularly among elderly individuals and young children, is a major cause for alarm. Estimates suggest a mortality rate nearing 50% in these vulnerable populations, raising the specter of a severely strained healthcare system, especially considering the lingering effects of the COVID-19 pandemic on already overburdened hospitals, particularly in rural areas.… Continue reading
The US government has recently allocated $176 million to Moderna for the development of an mRNA pandemic flu vaccine. As a taxpayer, it’s concerning to see such a large sum of money being funneled into a private corporation for vaccine development. The idea that we, as taxpayers, should foot the bill for the creation of a vaccine that will potentially save millions of lives seems reasonable on the surface. However, the issue lies in the privatization of profits that often follows these types of investments.
It’s frustrating to witness this pattern of socializing the cost of vaccine development while allowing corporations to reap the benefits.… Continue reading
As I read the heart-wrenching stories shared by individuals who have lost loved ones to glioblastoma, my heart aches with empathy and understanding. The pain, the suffering, and the devastation caused by this aggressive brain tumor are unimaginable. The toll it takes on families, the despair it brings, the helplessness felt as we watch our loved ones deteriorate before our eyes, is a burden no one should have to bear.
The news of a new mRNA cancer vaccine that triggers a fierce immune response to fight malignant brain tumors is nothing short of revolutionary. The study, which shows promising results in both murine models and canine trials, offers a glimmer of hope amidst the darkness of this devastating disease.… Continue reading
Matt Underwood 
John Q. Hosedrinker